| Account | Description | FY 2016 Spending |
FY 2017 House 2 |
|---|---|---|---|
| 4512-0103 | HIV/AIDS Prevention Treatment and Services For Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome services and programs and related services for persons affected by the associated conditions of viral hepatitis, sexually transmitted infections, and tuberculosis; provided, that particular attention shall be paid to direct funding proportionately to each of the demographic groups afflicted by HIV/AIDS and associated conditions; and provided further, that no funds from this item shall be expended for disease research in fiscal year 2017 |
33,120,000 | 32,934,597 |